Los Angeles, CA, United States of America

David S Eisenberg

USPTO Granted Patents = 22 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 2.7

ph-index = 9

Forward Citations = 278(Granted Patents)

Location History:

Los Angeles, CA (US) (1995 - 2022)
Tustin, CA (US) (2023)

Company Filing History:

20 out of 15,488

University of California

University of Washington

patents

5. 2 out of 832,891

Other

patents

where one patent can have more than one assignee

Years Active: 1995-2023

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11627675 - Extensible display screen apparatus for mobile electronic device (2023-04-11),

2. 11390646 - Structure-based peptide inhibitors of α-synuclein aggregation (2022-07-19),

3. 11028128 - Inhibition of the aggregation of transthyretin by specific binding of peptides to aggregation-driving segments (2021-06-08),

4. 10934332 - Structure-based peptide inhibitors that target the Tau VQIINK fibrillization segment (2021-03-02),

5. 10815271 - Structure-based peptide inhibitors of alpha-synuclein aggregation (2020-10-27),

6. 10400010 - Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics (2019-09-03),

7. 9873718 - Structure-based peptide inhibitors of P53 aggregation as a new approach to cancer therapeutics (2018-01-23),

8. 9766850 - Multiple screen arrangement for mobile device (2017-09-19),

9. 9463195 - Dissolution of amyloid fibrils by flavonoids and other compounds (2016-10-11),

10. 8754034 - Structure-based design of peptide inhibitors of amyloid fibrillation (2014-06-17),

11. 7459439 - Granulysin peptides and methods of use thereof (2008-12-02),

12. 7314916 - Methods and materials for characterizing and modulating interaction between heregulin and HER3 (2008-01-01),

13. 7125680 - Methods and materials for characterizing and modulating interaction between heregulin and HER3 (2006-10-24),

14. 6892139 - Determining the functions and interactions of proteins by comparative analysis (2005-05-10),

15. 6772069 - Determining protein function and interaction from genome analysis (2004-08-03),

Title: Unveiling the Innovation Journey of David S Eisenberg

Introduction:

David S Eisenberg, a prolific inventor based in Los Angeles, CA (US), has made remarkable contributions in the field of technology and healthcare. With an impressive portfolio of 22 patents, Eisenberg continues to revolutionize the industry with his groundbreaking inventions.

Latest Patents:

1. Extensible display screen apparatus for mobile electronic device: A cutting-edge invention that enhances the functionality of mobile electronic devices by providing additional information through an extensible display screen apparatus.

2. Structure-based peptide inhibitors of α-synuclein aggregation: Eisenberg's innovative peptides bind to α-synuclein molecules, offering a solution to inhibit α-synuclein amyloidogenic aggregation and related cytotoxicity, with potential applications in treating neurodegenerative diseases.

Career Highlights:

Eisenberg has been associated with renowned institutions such as the University of California and Harvard College. His expertise and innovative mindset have significantly impacted the research and development landscape, reflecting his commitment to advancing technology and healthcare.

Collaborations:

Throughout his career, Eisenberg has collaborated with esteemed professionals in the field, including Edward M Marcotte and Lin Jiang. These collaborations have not only enriched his work but have also led to groundbreaking inventions that have shaped the industry.

Conclusion:

David S Eisenberg's relentless pursuit of innovation and dedication to improving technology and healthcare have solidified his position as a prominent inventor. His cutting-edge patents and collaborations showcase his commitment to driving progress and making a lasting impact in the world of inventions.

This text is generated by artificial intelligence and may not be accurate.